Skip to main content
SpringerLink
Log in

Zwangsstörungen

  • Chapter
  • First Online:
Neuro-/Psychopharmaka im Kindes- und Jugendalter

  • 6263 Accesses

Zusammenfassung

Die Zwangsstörungen zählen mit einer Prävalenz von 1–2 % zu den häufigsten Störungen im Kindes- und Jugendalter. Die Therapie der kindlichen Zwangsstörung orientiert sich am Schweregrad der Zwangsstörung und an dem Vorhandensein komorbider Störungen. Eine evidenzbasierte Therapie bei Kindern und Jugendlichen beinhaltet Elemente der Psychoedukation, der kognitiv-verhaltenstherapeutischen Psychotherapie (KVT) und einer pharmakologischen Behandlung. Die Kombination von KVT und einer Medikation ist hierbei besonders wirksam. Selektive Serotonin-Wiederaufnahmehemmer (SSRIs) zeigen sich in verschiedenen Metaanalysen, die randomisierte und placebokontrollierte Studien an Kindern und Jugendlichen beinhalten, als hoch effektiv und sind Medikamente der ersten Wahl. Medikament der zweiten Wahl ist das trizyklische Antidepressivum Clomipramin. Zugelassen in Deutschland für die Behandlung bei Kindern und Jugendlichen mit Zwängen sind Sertralin und Fluvoxamin.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Literatur

  • AACAP Official Action (2012) Practice parameter for the assessment and treatment of children and adolescents. J Am Acad Child Psychiatry 51:98–113

    Article  Google Scholar 

  • Abramowitz JS, Taylor S, McKay D (2005) Potentials and limitations of cognitive treatments for obsessive-compulsive disorder. Cogn Behav Ther 34:140–147

    Article  PubMed  Google Scholar 

  • Alaghband-Rad J, Hakimshooshtary M (2009) A randomized controlled clinical trial of citalopram versus fluoxetine in children and adolescents with obsessive-compulsive disorder. Eur Child Adolesc Psychiatry 18:131–135

    Article  PubMed  Google Scholar 

  • Blier P, Habib R, Flament F (2006) Pharmacotherapies in the management of obsessive-compulsive disorder. Can J Psychiatry 51:417–430

    PubMed  Google Scholar 

  • Bloch MH (2006) A systematic review: antipsychotic augmentation with treatment refactory obsessive-compulsive disorder. Mol Psychiatry 11:622–632

    Article  CAS  PubMed  Google Scholar 

  • Bloch MH, Storch EA (2015) Assessment and management of treatment-refractory obsessive-compulsive disorder in children. J Am Acad Child Adolesc Psychiatry 54:251–261

    Article  PubMed  PubMed Central  Google Scholar 

  • Bloch MH, McGurie J, Landeros-Weisenberger A, Leckman JF, Pittenberger C (2010) Meta-analysis of the dose-response relationship of SSRI in obsessive-compulsive disorder. Mol Psychiatry 15:850–855

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Bridge JA, Iyengar S, Salary CB et al (2007) Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials. JAMA 297:1683–1696

    Article  CAS  PubMed  Google Scholar 

  • Cook EH, Wagner KD, March JS, Biedermann J, Landau P, Wolkow R, Messig M (2001) Long-term sertraline treatment of children and adolescents with obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry 40:1174–1181

    Article  Google Scholar 

  • Deutsche Gesellschaft für Psychiatrie, Psychotherapie, Psychosomatik und Nervenheilkunde (DGPPN) (2013) S3-Leitlinie Zwangsstörungen. AWMF Registernummer 038-017. http://www.awmf.org/leitlinien/detail/ll/038-017.html. Zugegriffen: 20. Nov. 2015

    Google Scholar 

  • DeVeaugh-Geiss J, Moroz G, Biederman J et al (1992) Clomipramine hydrochloride in childhood and adolescent obsessive-compulsive disorder – a multicenter trial. J Am Acad Child Adolesc Psychiatr 31:45–49

    Article  CAS  Google Scholar 

  • Dilling H, Mombour W, Schmidt MH (Hrsg) (2013) Internationale Klassifikation psychischer Störungen. ICD-10 Kapitel V (F) Klinisch-diagnostische Leitlinien, 9. Aufl. Huber, Bern

    Google Scholar 

  • Diniz JB, Shavitt RG, Fossaluza V, Koran L, Pereira CA, Miguel EC (2011) A double-blind, randomized, controlled trial of fluoxetine plus quetiapine or clomipramine versus fluoxetine plus placebo for obsessive-compulsive disorder. J Clin Psychopharmacol 31:763–768

    Article  CAS  PubMed  Google Scholar 

  • Dold M, Aigner M, Lanzenberger R, Kasper S (2013) Antipsychotic augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a meta-analysis of double-blind, randomized, placebo-controlled trials. Int J Neuropsychopharmacol 16:557–574

    Article  CAS  PubMed  Google Scholar 

  • Falkai P, Wittchen H-U (Hrsg) (2015) American Psychiatric Association. Diagnostisches und Statistisches Manual Psychischer Störungen DSM-5®. Hogrefe, Göttingen

    Google Scholar 

  • Freeman J, Garcia A, Frank H, Benito K, Conelea C, Walther M, Edmunds J (2014) Evidence-based update for psychosocial treatment for pediatric obsessive-compulsive disorder. J Clin Child Adolesc Psychol 43:7–26

    Article  PubMed  Google Scholar 

  • Geller DA, Biedermann J, Stewart SE, Mullin B, Martin A, Spencer T (2003) Which SSRI? A meta-analysis of pharmacotherapy trials in pediatric obsessive-compulsive disorder. Am J Psychiatry 160:1919–1929

    Article  PubMed  Google Scholar 

  • Gentile S (2011) Efficacy of antidepressant medications in children and adolescents with obsessive-compulsive disorder. A systematic appraisal. J Clin Psychopharmacotherapy 31:625–632

    Article  CAS  Google Scholar 

  • Grünblatt E, Tschakarjan S, Brezinka V, Walitza S (2014) Extraordinarily fast response to low-dose sertraline in a child with severe obsessive-compulsive disorder and high functioning serotonin transporter genotype. J Child Adol Psychopharmacol 24:102–104

    Article  Google Scholar 

  • Henry JA, Alexander CA, Sener EK (1995) Relative mortality from overdose of antidepressants. Br Med J 310:221–224

    Article  CAS  Google Scholar 

  • Leonard HL, Swedo SE, Rapoport JL, Koby EV, Lenane MC, Cheslow DL, Hamburger SD (1989) Treatment of obsessive-compulsive disorder with clomipramine and desipramine in children and adolescents. A double-blind crossover comparison. Arch Gen Psychiatry 46:1088–1092

    Article  CAS  PubMed  Google Scholar 

  • Li X (2005) Risperidone and Haloperidol augmentation of serotonin reuptake inhibitors in refactory obsessive-compulsive disorder. J Clin Psychiatry 66:736–743

    Article  CAS  PubMed  Google Scholar 

  • Liebowitz MR, Turner SM, Piacentini J, Beidel DC, Clarvit SR, Davies SO (2002) Fluoxetine in children and adolescents with ocd: a placebo-controlled trial. J Am Acad Child Adolesc Psychiatry 1:1431–1438

    Article  Google Scholar 

  • Masi G, Pfanner C, Brovedani P (2013) Antipsychotic augmentation of selective serotonin reuptake inhibitors in resistant tic-related obsessive-compulsive disorder in children and adolescents: a naturalistic comparative study. J Psychiatr Res 47:1007–1012

    Article  PubMed  Google Scholar 

  • Pallanti S, Quercioli L, Paiva RS, Koran LM (1999) Citalopram for treatment-resistant obsessive-compulsive disorder. Eur Psychiatry 14:101–106

    Article  CAS  PubMed  Google Scholar 

  • Pediatric OCD Treatment Study (POTS) Team (2004) Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial. JAMA 292:1969–1976

    Article  Google Scholar 

  • Riddle MA, Reeve EA, Yaryura-Tobias JA et al (2001) Fluvoxamine for children and adolescents with obsessive-compulsive disorder: a randomized, controlled, multicenter trial. J Am Acad Child Adolesc 40:222–229

    Article  CAS  Google Scholar 

  • Sanchez-Meca J, Rosa-Alcazar A, Iniesta-Sepulveda M, Rosa-Alcazar A (2014) Differential efficacy of cognitive-behavioral therapy and pharmacological treatments for pediatric obsessive-compulsive disorder: a meta-analysis. J Anxiety Disord 28:31–44

    Article  PubMed  Google Scholar 

  • Sayyah M, Boostani H, Ghaffari SM, Hosein A (2012) Effects of aripiprazole augmentation in treatment-resistant obsessive-compulsive disorder (a double blind clinical trial). Depress Anxiety 29:850–854

    Article  CAS  PubMed  Google Scholar 

  • Scahill L, Riddle MA, McSwiggin-Hardin M et al (1997) Children’s Yale-Brown Obsessive Compulsive Scale: reliability and validity. J Am Acad Child Psychiatry 36:844–852

    Article  CAS  Google Scholar 

  • Shah R, Uren Z, Baker A, Majeed A (2001) Deaths from antidepressants in England and Wales 1993–1997: analysis of a new national database. Psychol Med 31:1203–1211

    Article  CAS  PubMed  Google Scholar 

  • Simpson HB, Foa EB, Liebowitz MR et al (2008) A randomized, controlled trial of cognitive-behavioral therapy for augmenting pharmacotherapy in obsessive-compulsive disorder. Am J Psychiatry 165:621–630

    Article  PubMed  PubMed Central  Google Scholar 

  • Skapinakis P (2007) Antipsychotic augmentation of serotonergic antidepressant in treatment-resistant obsessive-compulsive disorder: a meta-analysis of the randomized controlled trials. Euro Neuropsychopharmacol 17:79–93

    Article  CAS  Google Scholar 

  • Stewart SE, Hezel D, Stachton AC (2012) Assessment and medication management of paediatric obsessive-compulsive disorder. Drugs 72:881–893

    Article  CAS  PubMed  Google Scholar 

  • Thomsen PH (2013) Obsessive-compulsive disorder. Eur Child Adolesc Psychiatry 22(Suppl 1):23–28

    Article  Google Scholar 

  • Vloet T, Simons M, Herpertz-Dahlmann B (2012) Psychotherapeutische und medikamentöse Behandlung der kindlichen Zwangsstörung. Z Kinder Jugendpsychiatr Psychother 40:29–39

    Article  PubMed  Google Scholar 

  • Watson HJ, Rees CS (2008) Meta-analysis of randomized, controlled treatment trials for pediatric obsessive-compulsive disorder. J Child Psychol Psychiatry 49:489–498

    Article  PubMed  Google Scholar 

  • Walitza S (2014) Zwangsstörungen im DSM-5: Was ist neu? Z Kinder Jugendpsychiatr Psychother 42:121–126

    Article  PubMed  Google Scholar 

  • Walitza S, Melfsen S, Jans T, Zellmann H, Wewetzer C, Warnke A (2011) Zwangsstörungen im Kindes- und Jugendalter/Obsessive-compulsive disorder in children and adolescents. Dtsches Ärztebl Int 108(11):173–179

    Google Scholar 

  • Wewetzer G, Wewetzer Ch (2012) Zwangsstörung bei Kindern und Jugendlichen – Ein Therapiemanual. Hogrefe, Göttingen

    Google Scholar 

  • Wewetzer G, Wewetzer Ch (2014) Therapie der Zwangsstörung im Kindes- und Jugendalter. Kindheit Entwicklung 23:102–112

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Abteilung für Kinder- und Jugendpsychiatrie und Psychotherapie, Kliniken der Stadt Köln gGmbH, Florentine-Eichler-Strasse 1, 51067, Köln, Deutschland

    Prof. Dr. med. Christoph Wewetzer

  2. Zentrum für Kinder- und Jugendpsychiatrie, Universität Zürich, Neumünsterallee 9, 8032, Zürich, Schweiz

    Prof. Dr. med. Susanne Walitza

Authors
  1. Prof. Dr. med. Christoph Wewetzer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Prof. Dr. med. Susanne Walitza
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Christoph Wewetzer .

Editor information

Editors and Affiliations

  1. Zentrum für Seelische Gesundheit, Universitätsklinikum Würzburg, Würzburg, Germany

    Manfred Gerlach

  2. Privatklinik für Seelische Gesundheit, J, HEMERA Klinik, Bad Kissingen, Germany

    Claudia Mehler-Wex

  3. Zentrum für Kinder- und Jugendpsychiatri, Universität Zürich, Zürich, Zürich, Switzerland

    Susanne Walitza

  4. Zentrum für Seelische Gesundheit, Universitätsklinikum Würzburg, Würzburg, Bayern, Germany

    Andreas Warnke

  5. Abteilung Kinder Jugendpsychiatrie, Kliniken der Stadt Köln gGmbH, Köln, Germany

    Christoph Wewetzer

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Wewetzer, C., Walitza, S. (2016). Zwangsstörungen. In: Gerlach, M., Mehler-Wex, C., Walitza, S., Warnke, A., Wewetzer, C. (eds) Neuro-/Psychopharmaka im Kindes- und Jugendalter. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-48624-5_27

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-48624-5_27

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-48623-8

  • Online ISBN: 978-3-662-48624-5

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation